/Companies

BrainsGate

14 known investors

Find your way into BrainsGate

Sign up to see every warm intro you have to BrainsGate

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BrainsGate team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.

Investors · 14

Also in the syndicate · 8

AgateAlice LabBNPleadBNP Joint Capital FundleadElron Electronic industriesJohnson & Johnson Development CorporationleadMB Venture CapitalMedtronic

Funding

SEC filings, press & company announcements

$14M disclosed across 1 of 3 rounds · 2008–2020

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does BrainsGate do?
BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.
Who are BrainsGate's investors?
BrainsGate's investors include Agate Medical Investments LP, Cipio Partners, Elron Ventures, JJDC, Pitango, Spero Ventures.
How much funding has BrainsGate raised?
BrainsGate has disclosed $14M raised across 1 of its 3 known rounds.